No matter how much they earn, Bioport's creative accounting ALWAYS shows a loss

August 6, 2007

Their stock is at 8.75. The company went public last November, with

the stock's opening price at 12 or 12.5.

It's not only the vaccinees who get burned -- the investors do too!

No matter what the company earns, Bioport's managers manage to spend

more. Remember the $200,000 for furniture for the office of the

President, Fuad el-Hibry, who was only occasionally in his Lansing

office, since he lives in land? --Meryl

NEWS03/708060354/1001/NEWS

Published August 6, 2007

Emergent BioSolutions posts loss

W. Steele

Lansing State Journal

Emergent BioSolutions Inc., which runs its main manufacturing

operation in Lansing, posted a $4.96 million loss in the second quarter.

The loss, at 17 cents per share, was more than the $3.05 million, or

14 cents per share, the Rockville, Md.-based company lost a year

earlier.

Revenue, however, grew to $23.19 million during the quarter on sales

growth of its BioThrax anthrax vaccine, made in Lansing. That was

nearly double the $11.45 million in revenue BioSolutions posted a

year earlier.

For the first six months of the year, Emergent's loss of $7.65

million was slightly better than the $7.69 million it lost through

June 2006.

Officials said earnings remained on target for the year, as more

orders of BioThrax are expected from the departments of Defense and

Health and Human Services.

" We remain confident that both of the contracts for new supply

agreements for BioThrax with our U.S. government customers will be

signed and we expect this will be accomplished before the end of the

third quarter, which should position us well for strong financial

performance in the future, " R. Don Elsey, senior vice president and

chief financial officer said in a statement.

Meryl Nass, MD

Mount Desert Island Hospital

Bar Harbor, Maine 04609

207 288-5081 ext. 220

Recommended Posts